Literature DB >> 25192381

It's not black and white: individualizing metformin treatment in type 2 diabetes.

Jose C Florez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25192381     DOI： 10.1210/jc.2014-2733

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Deciphering the Effect of Metformin on Prostate Cancer Risk by Ethnicity.

Authors:  Edward Uchio; Frank L Meyskens; Ping H Wang
Journal:  Cancer Prev Res (Phila)       Date:  2016-07-18

2.  The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Authors:  Saira Khan; Jianwen Cai; Matthew E Nielsen; Melissa A Troester; James L Mohler; Elizabeth T H Fontham; Laura Farnan; Bettina F Drake; Andrew F Olshan; Jeannette T Bensen
Journal:  Cancer Causes Control       Date:  2018-09-28       Impact factor: 2.506

3.  Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis.

Authors:  Aya Mousa; Tone Løvvik; Ijäs Hilkka; Sven M Carlsen; Laure Morin-Papunen; Kristiina Tertti; Tapani Rönnemaa; Argyro Syngelaki; Kypros Nicolaides; Hassan Shehata; Christy Burden; Jane E Norman; Janet Rowan; Jodie M Dodd; William Hague; Eszter Vanky; Helena J Teede
Journal:  BMJ Open       Date:  2020-05-21       Impact factor: 2.692

4.  Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial.

Authors:  Johanna M G Stultiens; Wiebe M C Top; Dorien M Kimenai; Philippe Lehert; Otto Bekers; Coen D A Stehouwer; Adriaan Kooy; Steven J R Meex
Journal:  Cardiovasc Diabetol       Date:  2022-04-04       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.